Drug Shortage Report for SANDOZ ANAGRELIDE
Report ID | 102534 |
Drug Identification Number | 02260107 |
Brand name | SANDOZ ANAGRELIDE |
Common or Proper name | ANAGRELIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ANAGRELIDE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-12-20 |
Estimated end date | Unknown |
Actual end date | 2020-02-04 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2023-11-17 | French | Compare |
v13 | 2023-11-17 | English | Compare |
v12 | 2021-01-19 | French | Compare |
v11 | 2021-01-19 | English | Compare |
v10 | 2020-11-26 | French | Compare |
v9 | 2020-11-26 | English | Compare |
v8 | 2020-06-29 | French | Compare |
v7 | 2020-06-29 | English | Compare |
v6 | 2020-05-25 | French | Compare |
v5 | 2020-05-25 | English | Compare |
v4 | 2020-02-03 | French | Compare |
v3 | 2020-02-03 | English | Compare |
v2 | 2020-01-08 | French | Compare |
v1 | 2020-01-08 | English | Compare |
Showing 1 to 14 of 14